Novartis AG (NVS)
Novartis AG Statistics
Share Statistics
Novartis AG has 1.98B shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 1.98B |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 6.56% |
| Shares Floating | 1.98B |
| Failed to Deliver (FTD) Shares | 15 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 4.42M, so 0.23% of the outstanding shares have been sold short.
| Short Interest | 4.42M |
| Short % of Shares Out | 0.23% |
| Short % of Float | 0.23% |
| Short Ratio (days to cover) | 3.7 |
Valuation Ratios
The PE ratio is 16.46 and the forward PE ratio is 12.31. Novartis AG's PEG ratio is -0.99.
| PE Ratio | 16.46 |
| Forward PE | 12.31 |
| PS Ratio | 3.8 |
| Forward PS | 3.7 |
| PB Ratio | 4.46 |
| P/FCF Ratio | 14.23 |
| PEG Ratio | -0.99 |
Enterprise Valuation
Novartis AG has an Enterprise Value (EV) of 222.71B.
| EV / Earnings | 18.65 |
| EV / Sales | 4.31 |
| EV / EBITDA | 10.75 |
| EV / EBIT | 15.31 |
| EV / FCF | 16.13 |
Financial Position
The company has a current ratio of 1.04, with a Debt / Equity ratio of 0.71.
| Current Ratio | 1.04 |
| Quick Ratio | 0.84 |
| Debt / Equity | 0.71 |
| Total Debt / Capitalization | 41.51 |
| Cash Flow / Debt | 0.56 |
| Interest Coverage | 14.46 |
Financial Efficiency
Return on equity (ROE) is 0.27% and return on capital (ROIC) is 16.89%.
| Return on Equity (ROE) | 0.27% |
| Return on Assets (ROA) | 0.12% |
| Return on Capital (ROIC) | 16.89% |
| Revenue Per Employee | $681,601.94 |
| Profits Per Employee | $157,360.67 |
| Employee Count | 75,883 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 2.24 |
Taxes
| Income Tax | 1.7B |
| Effective Tax Rate | 0.12 |
Stock Price Statistics
The stock price has increased by 16.1% in the last 52 weeks. The beta is 0.49, so Novartis AG's price volatility has been higher than the market average.
| Beta | 0.49 |
| 52-Week Price Change | 16.1% |
| 50-Day Moving Average | 106.8 |
| 200-Day Moving Average | 108.59 |
| Relative Strength Index (RSI) | 53.4 |
| Average Volume (20 Days) | 2.14M |
Income Statement
In the last 12 months, Novartis AG had revenue of 51.72B and earned 11.94B in profits. Earnings per share was 5.97.
| Revenue | 51.72B |
| Gross Profit | 38.9B |
| Operating Income | 14.54B |
| Net Income | 11.94B |
| EBITDA | 20.71B |
| EBIT | 14.54B |
| Earnings Per Share (EPS) | 5.97 |
Balance Sheet
The company has 11.46B in cash and 31.26B in debt, giving a net cash position of -19.8B.
| Cash & Cash Equivalents | 11.46B |
| Total Debt | 31.26B |
| Net Cash | -19.8B |
| Retained Earnings | 0 |
| Total Assets | 102.25B |
| Working Capital | 1.01B |
Cash Flow
In the last 12 months, operating cash flow was 17.62B and capital expenditures -3.81B, giving a free cash flow of 13.8B.
| Operating Cash Flow | 17.62B |
| Capital Expenditures | -3.81B |
| Free Cash Flow | 13.8B |
| FCF Per Share | 6.86 |
Margins
Gross margin is 75.2%, with operating and profit margins of 28.12% and 23.09%.
| Gross Margin | 75.2% |
| Operating Margin | 28.12% |
| Pretax Margin | 26.37% |
| Profit Margin | 23.09% |
| EBITDA Margin | 40.05% |
| EBIT Margin | 28.12% |
| FCF Margin | 26.69% |
Dividends & Yields
NVS pays an annual dividend of $3.28, which amounts to a dividend yield of 3.02%.
| Dividend Per Share | $3.28 |
| Dividend Yield | 3.02% |
| Dividend Growth (YoY) | -13.24% |
| Payout Ratio | 55.73% |
| Earnings Yield | 5.37% |
| FCF Yield | 6.26% |
Analyst Forecast
The average price target for NVS is $121, which is 8.9% higher than the current price. The consensus rating is "Hold".
| Price Target | $121 |
| Price Target Difference | 8.9% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
Stock Splits
The last stock split was on Apr 9, 2019. It was a forward split with a ratio of 279:250.
| Last Split Date | Apr 9, 2019 |
| Split Type | forward |
| Split Ratio | 279:250 |
Scores
| Altman Z-Score | 3.28 |
| Piotroski F-Score | 7 |